Doctor of Philosophy (biological sciences). Garvan / UNSW (2014-2017).
Bachelor of Philosophy (science), first class honours. Australian National University (2009-12).
Dr Ira Deveson graduated with a Bachelor of Philosophy from the Australian National University in 2012. He completed a PhD at the Garvan Institute from 2014-2017, supervised by Prof John Mattick and Dr Tim Mercer. Dr Deveson's PhD was focused on genome/transcriptome research and bioinfomatics, and earned him recognition with the JD Catcheside prize from the Genomics Society of Australasia.
Dr Deveson was awarded an Early Career Fellowship from the Cancer Institute NSW (2018) and a prestigious Investigator Grant (EL2) from the NHMRC and Medical Research Futures Fund (2020). After a post-doc stint under Dr Tim Mercer, he was appointed as Head of the Genomic Technologies Group within the Kinghorn Centre for Clinical Genomics in 2020. Under Dr Deveson's leadership, the Genome Technologies Group is testing and developing cutting-edge molecular and computational tools for research and clinical genomics.
Garvan Rising Star Award (2018).
DG Catcheside Prize, Genetics Society of Australasia (2017).
Stuart Furler Travel Award, Garvan Institute (2016).
Graduate Research Excellence Scholarship, UNSW (2014-2017).
3 Minute Thesis winner, Garvan Institute (2014).
University Medal for Biology, Australian National University (2012).
MRFF Investigator Grant – Emerging Leadership Level 2 (2020-2025).
Developing synthetic DNA reference standards (sequins) to ensure accuracy in emerging genomic technologies.
Cancer Institute NSW Early Career Fellowship (2018-2020).
Representing the cancer genome with synthetic spike-in controls.
UNSW-USA Networks of Excellence Mobility Grant (2019).
Interrogating the human transcriptome with high-throughput CRIPSR knockout screens.